Squarepoint Ops LLC - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 127 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
Squarepoint Ops LLC ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$25,708
-38.8%
19,929
-28.8%
0.00%
Q4 2022$42,009
-93.7%
28,006
-95.1%
0.00%
-100.0%
Q3 2022$669,000
+1162.3%
566,815
+3112.5%
0.00%
Q1 2022$53,000
-86.9%
17,644
-88.5%
0.00%
-100.0%
Q4 2021$405,000
-67.2%
152,820
-55.0%
0.00%
-75.0%
Q3 2021$1,233,000
+8.6%
339,558
+29.8%
0.00%0.0%
Q2 2021$1,135,000
+234.8%
261,506
+163.8%
0.00%
+100.0%
Q1 2021$339,000
-36.9%
99,142
-55.7%
0.00%
-71.4%
Q3 2020$537,000
-19.9%
223,851
-38.9%
0.01%
-36.4%
Q2 2020$670,000
+241.8%
366,344
+191.1%
0.01%
+120.0%
Q1 2020$196,000
-85.2%
125,857
-79.7%
0.01%
-37.5%
Q4 2019$1,324,000
-35.8%
618,662
-43.9%
0.01%
-55.6%
Q3 2019$2,062,000
+56.8%
1,102,470
+118.8%
0.02%
+38.5%
Q2 2019$1,315,000
+48.9%
503,961
+46.6%
0.01%
+44.4%
Q1 2019$883,000
+2286.5%
343,709
+2025.7%
0.01%
Q4 2018$37,000
-75.3%
16,169
-65.3%
0.00%
-100.0%
Q3 2018$150,000
-40.9%
46,591
-48.1%
0.00%
-33.3%
Q2 2018$254,000
+669.7%
89,822
+594.4%
0.00%
+200.0%
Q3 2017$33,000
-66.0%
12,936
-56.0%
0.00%
-66.7%
Q1 2017$97,000
-52.9%
29,385
-66.1%
0.00%
-62.5%
Q4 2016$206,00086,7000.01%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 9,105,691$30,140,0005.99%
Sio Capital Management, LLC 1,888,181$6,250,0003.50%
DAFNA Capital Management LLC 473,478$1,567,0001.32%
Cormorant Asset Management, LP 2,000,000$6,620,0000.96%
Ghost Tree Capital, LLC 1,100,000$3,641,0000.68%
Rhenman & Partners Asset Management AB 1,282,000$4,243,0000.67%
Palo Alto Investors LP 4,254,623$14,083,0000.67%
NEA Management Company, LLC 3,243,150$10,375,0000.36%
Telemetry Investments, L.L.C. 170,000$563,0000.25%
NJ State Employees Deferred Compensation Plan 355,000$1,175,0000.22%
View complete list of RIGEL PHARMACEUTICALS INC shareholders